Serotonin Activates Dendritic Cell Function in the Context of Gut Inflammation  by Li, Nan et al.
The American Journal of Pathology, Vol. 178, No. 2, February 2011
Copyright © 2011 American Society for Investigative Pathology.
Published by Elsevier Inc. All rights reserved.
DOI: 10.1016/j.ajpath.2010.10.028Gastrointestinal, Hepatobiliary, and Pancreatic Pathology
Serotonin Activates Dendritic Cell Function in the
Context of Gut InflammationNan Li,*† Jean-Eric Ghia,*† Huaqing Wang,*
Jessica McClemens,* Francine Cote,‡
Youko Suehiro,§ Jacques Mallet,†
and Waliul I. Khan*
From the Departments of Pathology and Molecular Medicine and
Medicine,* Farncombe Family Digestive Health Research Institute,
McMaster University, Hamilton, Ontario, Canada; the Centre
National de la Recherche Scientifique,† Biotechnologie and
Biotherapie UMR 7225, Hôpital de la Pitié-Salpêtrière, Paris,
France; the CNRS/Université UMR 8147,‡ Hôpital Necker-Enfants
Malades, Paris, France; and the Department of Molecular
Genetics,§ Medical Institute of Bioregulation, Kyushu University,
Fukuoka, Japan
Mucosal inflammation in the gut is characterized by
infiltration of innate and adaptive immune cells and by
an alteration in serotonin–producing enterochromaffin
cells. We investigated the role of serotonin in the func-
tion of dendritic cells (DCs) and sequential T-cell activa-
tion in relation to generation of gut inflammation. DCs
isolated from tryptophan hydroxylase-1–deficient
(TPH1/) mice, which have reduced serotonin in the
gut, and wild-type (TPH1/) mice with or without dex-
tran sulfate sodium (DSS)–induced colitis were stimu-
lated with lipopolysaccharide to assess interleukin-12
(IL-12) production. Isolated DCs from TPH1/ and
TPH1/mice were also coculturedwith CD4 T cells of
naive TPH1/ mice to assess the role of serotonin in
priming T cells. In addition, serotonin-pulsed DCs were
transferred to TPH1/mice to assess the effect on DSS-
induced colitis. Consistent with a reduced severity of
colitis, DCs from DSS-induced TPH1/ mice produced
less IL-12 compared with the TPH1/ mice. In vitro
serotonin stimulation restored the cytokine production
from TPH1/ DCs and adoptive transfer of serotonin-
pulsed DCs into TPH1/ up-regulated colitis. Further-
more, CD4 T cells primed by TPH1/ DCs pro-
duce reduced the levels of IL-17 and interferon-.
This study provides novel information on sero-
tonin-mediated immune signaling and promotion
of interactions between innate and adaptive im-
mune responses in the context of gut inflammation,
662which may ultimately lead to improved strategies to
combat gut inflammatory disorders. (Am J Pathol
2011, 178:662–671; DOI: 10.1016/j.ajpath.2010.10.028)
Inflammation in the gastrointestinal (GI) tract is char-
acterized by mucosal recruitment of activated cells
from both the innate and adaptive immune systems. In
addition to immune cells, inflammation in the gut is
associated with an alteration in serotonin producing
enterochromaffin (EC) cells. EC cells are the most well-
characterized subset of GI endocrine cells, which are
dispersed throughout the GI mucosa and are the main
source of serotonin in the gut.1–4 Serotonin is an im-
portant enteric mucosal signaling molecule that influ-
ences gut physiology (motor and secretory function)
after inflammation and is considered important in gut
function. Changes in intestinal EC cell numbers and
serotonin levels are observed in patients with inflam-
matory bowel disease (IBD)5–7 and also in experimen-
tal colitis.8,9 In addition, an alteration in the number of
EC cells and in serotonin level is observed in enteric
infection–induced inflammation in the gut10–13 and
functional disorders such as irritable bowel syndrome
(IBS).7,14 The association between alteration in EC cell
numbers and serotonin production and various GI dis-
eases highly emphasizes the significance of serotonin
in intestinal homeostasis. Because of the strategic lo-
cation of EC cells in gut mucosa, it is likely that sero-
tonin plays an important role in immune activation in
relation to gut pathology and pathophysiology in vari-
ous GI disorders, including IBD.
ECcellssynthesizeserotoninfromitsprecursorL-trypt-
ophan. Tryptophan hydroxylase (TPH) catalyzes the
rate-limiting step in the synthesis of serotonin from
tryptophan and has been detected prominently in EC
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forms of TPH enzymes that regulate the serotonin sys-
tem. TPH1 is mainly present in peripheral organs, such
as the EC cells and spleen, whereas TPH2 predomi-
nates in the brainstem and myenteric plexus neu-
rons.16,17
Recently, using tryptophan hydroxylase-1–deficient
(TPH1/) mice, which have significantly reduced
amounts of serotonin in the gut, and mice treated with
the serotonin synthesis inhibitor para-chloro-D, L-phe-
nylalanine (PCPA), we demonstrated a critical role of
serotonin in the generation of colitis in two different
models of colitis [dextran sulfate sodium (DSS) and
dinitrobenzene sulfonic acid (DNBS)].8 Decreased se-
verity of colitis and down-regulation of proinflammatory
cytokine production were observed in TPH1/ mice
compared with wild-type mice and in PCPA-treated
mice after induction of colitis.
Dendritic cells (DCs) are important innate immune
cells and perform a key role in activation of immune
response. DCs are the major source of proinflamma-
tory mediators, including cytokines, reactive oxygen,
and nitrogen intermediates, and play a critical role in
the generation of inflammation in the intestinal tract.
The character of a T-cell (key player in adaptive im-
mune system) response, whether effector T cells (TH1,
TH2, TH17) or regulatory T cells (Tr, TH3), reflects in-
struction by the initiating DCs. Studies on human DCs
revealed the presence of different serotoninergic re-
ceptors on DCs, and functional studies indicated that
activation of serotonin 4 and serotonin 7 receptor en-
hanced the release of the cytokines interleukin-1 (IL-
1) and IL-8.18 Although DCs expressing serotonin
receptors are situated close to EC cells, and are con-
sidered to play an important role in immune activation
and generation of intestinal inflammation, the role of
serotonin in modulating DC function in the context of
intestinal inflammation remains to be determined. In
this study we investigated the role of serotonin in the
function of DCs and sequential T-cell activation in re-
lation to generation of gut inflammation in a well-de-
fined experimental model of colitis.
Materials and Methods
Animals
TPH1/ mice on C57BL/6 background were originally
produced by gene mutation as described by Côté et
al.19 Briefly, exon 2 of the TPH1 locus has been sub-
stituted by the nlslacZneopolyA cassette. These mice
are viable, express normal amounts of serotonin in the
brain, and show no observed food intake differences or
body weight difference from wild-type mice. Breeding
pairs of TPH1/ mice and their wild-type (TPH1/)
littermates were obtained from Université Pierre et Ma-
rie Curie, CNRS, Paris, France, and were kept and bred
under specific pathogen-free conditions. C57BL/6were purchased from Taconic (Albany, NY). All exper-
iments were approved by the McMaster University An-
imal Ethics Committee and conducted under the Ca-
nadian Guidelines for Animal Research.
Induction of DSS Colitis
DSS (mol. wt., 40 kDa; ICN Biomedicals Inc, Soho, Ohio)
was added to the drinking water in a final concentration
of 5% (wt/vol) for 5 days.8,20 Controls were all time
matched and consisted of mice that received normal
drinking water only. Mean DSS consumption was noted
per cage each day.
Assessment of the Severity of Colitis: Disease
Activity Index
Disease activity index (DAI) scores have historically cor-
related well with the pathological findings in a DSS-in-
duced model of ulcerative colitis.21 DAI is the combined
score of weight loss, stool consistency, and bleeding.
Scores were defined as follows: weight: 0, no loss; 1, 5%
to 10%; 2, 10% to 15%; 3, 15% to 20%; and 4, 20%
weight loss; stool: 0, normal; 2, loose stool; and 4, diar-
rhea; and bleeding: 0, no blood; 2, presence (Hemoccult
II positive result; Beckman Coulter, Fullerton, CA); and 4,
gross blood. The DAI was scored from day 0 to day 5
during DSS treatment.
Macroscopic Scores
Five days after the beginning of the DSS treatment, the
mice were sacrificed and the abdominal cavity was
opened, the colon was located, and observations on
distension, fluid content, hyperemia, and erythema
were recorded. The colon was removed and opened
longitudinally, and macroscopic damage was immedi-
ately assessed. Macroscopic scores were performed
using a previously described scoring system for DSS
colitis.21
Colonic Histology and Myeloperoxidase Activity
Formalin-fixed colon segments were paraffin embed-
ded and 3-m sections were stained with H&E. Colonic
damage was scored based on a published scoring
system that considers architectural derangements,
goblet cell depletion, edema or ulceration, and degree
of inflammatory cell infiltrate.21 Myeloperoxidase
(MPO) activity was determined after an established
protocol.22 Briefly, MPO activity, used as a marker of
neutrophilic infiltration, was extracted and the activity
was measured using a modified version of the method
described by Bradley et al.23 Tissue samples were
homogenized (50 mg/ml) in ice-cold 50 mmol/L potas-
sium phosphate buffer (pH 6.0) containing 0.5% hexa-
decyl trimethyl ammonium bromide (Sigma, Missis-
sauga, Ontario, Canada). The homogenate was freeze
thawed three times, briefly sonicated, and then centri-
fuged at 12 000  g for 12 minutes at 4°C. The super-
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(Sigma) and hydrogen peroxide. The absorbance of
the colorimetric reaction was measured by a spectro-
photometer. MPO is expressed in units per milligram of
wet tissue, with 1 unit being the quantity of enzyme
able to convert 1 mol of hydrogen peroxide to water in
1 minute at room temperature.
DC and CD4 T-Cell Isolation
Spleens were cut into small pieces and digested for 30
minutes at 37°C with spleen dissociation medium
(Stem Cell Technology, Vancouver, British Columbia,
Canada). After incubation dissociation and centrifuga-
tion, the resulting cell suspension was treated with
supplemented medium [PBS: 2% fetal bovine serum
(FBS) and 1 mmol/L EDTA]. Spleen CD11c cells were
isolated by positive selection using EasySep mouse
CD11c selection kit (Stem Cell Technology, Vancou-
ver, BC, Canada ) following manufacturer’s instruction.
CD4 T cells were isolated from the mixed splenocytes
by negative selection using an EasySep mouse CD4
T cell enrichment cocktail with magnetic nanoparticles
(Stem Cell Technologies, Vancouver, BC, Canada).
Cell purity was 90% as determined by flow cytometry,
using antimouse CD4 (LT34) monoclonal antibody (BD
Pharmingen, San Diego, CA).
Figure 1. Effects of the lack of serotonin in the gut in the development of DS
(A), IFN- (B), and IL-12p40 (C)]. Histamine (D) and PGE2 (E) levels in DSS
drinking water to induce colitis and were sacrificed on day 5 after DSS. Eac
DSS-treated TPH1/ mice compared with DSS-treated TPH1/ mice. F: IL-
cultured with medium or with the presence of LPS (100 ng/ml) *P  0.05 compared
of two independent experiments with quadruplicated cultures using seven mice, mImmunophenotyping of Isolated CD11c Cells
After MACS isolation, CD11c preparations were sur-
face stained using various anti-mouse monoclonal an-
tibodies. The following antibodies were used: anti-
major histocompatibility complex II (MHCII)–phyco-
erythrin (PE), anti–CD40–fluorescein isothiocyanate,
anti–CD80–peridinin chlorophyll protein–Cy5.5, and
anti–CD86-allophycocyanin. All antibodies were pur-
chased from BD Biosciences except anti–MHCII-PE
(eBioscience, San Diego, CA). Specific phenotyping
procedures used four-color analysis to determine var-
ious DC subsets. Data were collected on a BD LSR II
cytometer using FACSDiva software (BD Biosciences,
Mississawga, ON, Canada) and analyzed using FlowJo
software (Treestar Inc, Ashland, OR).
Bone Marrow Isolation
Bone marrow cells were harvested from the femur and
tibiae of naive mice as previously described24 and
cultured in RPMI 1640 medium containing 10% FBS,
100 U/ml of penicillin, 100 g/ml of streptomycin, 2
mmol/L L-glutamine, 0.1% 2-mercaptoethanol, 0.1
mmol/L nonessential amino acids, 1 mmol/L sodium
pyruvate, and 20 ng/ml of recombinant murine granu-
locyte-macrophage colony-stimulating factor (GM-
CSF; PeproTech, Rocky Hill, NJ). Three and six days
d colitis. Effects of the lack of serotonin on proinflammatory cytokines [IL-17
d colitis. TPH1/ and TPH1/ mice were given a 5% DSS solution in the
represents mean  SEM from eight mice. Significantly lower (*P  0.05) in
roduction from DC (2.106 cells/ml) isolated from colitic (TPH1/) mice and
/S-induce
-induce
h value
12p40 pwith medium. **P  0.05 compared with TPH1 . Data are representative
ean  SEM.
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medium supplemented with GM-CSF. On day 7, DC
culture was completed.
Adoptive Transfer of Spleen CD11c Cells
Spleen CD11c cells from TPH1/ mice were isolated
as described above. A total of 2.106 cells per mouse
were injected i.p. into TPH1/ host mice. After 24 hours,
5% DSS-induced colitis was induced for 5 days.
Cytokine Assessment from Bone Marrow–
Derived DCs, DCs, and T Cells Cocultured
with DCs
Myeloid DCs (106/ml) were cultured with increasing
doses (107 to 103M) of serotonin for 48 hours. Spleen
CD11c cells from colitic and noncolitic TPH1/ mice
were isolated as described above. CD11c DCs were
cultured and exposed to lipopolysaccharide (LPS) (100
ng/ml; Sigma) for 24 hours. The level of IL-12p40 was
determined in the presence or absence of serotonin
(107 and 105M) and/or nuclear factor B (NF-B) in-
hibitor, pyrrolidine dithiocarbamate (PDTC; 10.106M;
Sigma). For coculture, CD11c DCs from mice treated
with DSS were cultured and exposed to LPS (100 ng/ml)
for 24 hours before being cocultured with CD4 T cells
isolated from naive mice at a ratio of 1:3 (DC:T)25 in plate
coated with 10 g/ml of anti-CD3 and 2 g/ml of anti-
CD28. Cell culture supernatants were collected at days 3,
5, and 7 for cytokine analysis [interferon- (IFN-) and
IL-17]. Cytokine levels (IL-1, IL-12p40, IL-17, and IFN-)
were determined using enzyme-linked immunosorbent
assay (ELISA) commercial kit (R&D Systems, Minneapo-
lis, MN).
Colonic Cytokine Production
A colonic sample was homogenized in 700 L of Tris HCl
buffer containing protease inhibitors (Sigma). Samples
were centrifuged for 30 minutes, and the supernatant was
frozen at 80°C until assay. Cytokine levels [IL-1, IL-6,
and tumor necrosis factor- (TNF-)] were determined
using a commercial ELISA kit (R&D Systems). Cytokine
(IL-1, IL-6, IL-4, IL-12, and IL-17) and prostaglandin E2
(PGE2) levels were determined using a commercial
ELISA kit (R&D Systems).
Histamine Level
Histamine was extracted from each sample by adding
10 L of 0.2N HClO4 per milligram of tissue. Samples
were homogenized and supernatant was collected and
neutralized to pH 6.8 by addition of an equal volume of
1M potassium borate. Histamine levels were deter-
mined using a commercial ELISA kit (Beckman
Coulter).Statistical Analysis
Results are presented as mean  SEM. Statistical anal-
ysis was performed using one- or two-way analysis of
variance followed by the Student-Newman-Keuls multiple
comparisons post hoc analysis and P  0.05 was con-
sidered significant.
Results
Down-Regulation of Cytokine Production from
DCs and Attenuation of DSS-Induced Colitis in
Mice with Reduced Levels of Serotonin in the Gut
We confirmed our previous study8 showing that in
TPH1/ mice that have reduced serotonin in the gut,
acute colitis is significantly decreased after 5 days of DSS
treatment. Macroscopic and MPO activity decreased
significantly from 3.7  0.25 to 2.2  0.3 and 2.1  0.4
to 0.6  02, respectively. This reduction in the severity of
DSS-induced colonic inflammation in TPH1/ mice was
associated with down-regulation of IL-17, IFN-, and IL-
12p40 in colonic tissue (Figure 1, A–C). However, hista-
mine and PGE2 levels were not significantly modified
(Figure 1, D and E).
DCs are critical in the production of IL-12p40 in many
immune responses, including those associated with IBD.
To elucidate the mechanism by which serotonin is influ-
encing the development of colitis, we next assessed the
role of serotonin in DC function in relation to gut inflam-
mation. DCs isolated from TPH1/ mice with DSS-in-
Figure 2. Expression of MHCII, CD40, CD80, and CD86 by CD11c cells
isolated by positive selection using EasySep mouse CD11c selection kit.
CD40 and MHCII costaining of CD11c isolated DC from TPH1/ mouse
(A), CD80 and CD86 costaining of CD11c isolated DC from TPH1/mouse
(B), CD40 and MHCII costaining of CD11c isolated DC from TPH1/
mouse (C), and CD80 and CD86 costaining of CD11c isolated DCs from
TPH1/ mouse (D). Data are representative of six samples.
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pared with DCs isolated from TPH1/ mice when
stimulated with LPS for 24 hours (Figure 1F), implying a
role of serotonin-mediated activation of DCs in the patho-
genesis of colitis in this model. Interestingly, in control
conditions we also observed a significant decrease in the
amount of IL-12p40 released in the culture supernatant of
nonstimulated DCs (Figure 1A).
Analysis of cell surface molecules by flow cytometry
revealed the expression of MHCII, CD40, CD80, and
CD86 on the isolated CD11c cells from both the
TPH1/ and TPH1/ mice (Figure 2). CD11c cells
isolated from TPH1/ mice expressed MHCII (12%),
CD40 (27.5%), CD80 (1.7%), and CD86 (22.5%).
CD11c cells isolated from TPH1/ mice expressed
MHCII (9.2%), CD40 (26.8%), CD80 (1.5%), and CD86
(21.2%).
Serotonin Stimulates Cytokine Production fromDCs
The role of serotonin in DC function was further studied
by examining the ability of serotonin to stimulate naive
DCs. A significantly lower amount of IL-12p40 in the
Figure 3. Effect of the lack of serotonin on IL-12p40 produced by DCs.
A: IL-12p40 production from DCs (2.106 cells/ml) isolated from noncolitic
(TPH1/) mice and cultured with medium or with serotonin at two different
doses (107 and 105M). *P  0.05 compared with untreated TPH1/.
**P  0.05 compared with untreated TPH1/. B: IL-12p40 production from
DCs (2.106 cells/ml) isolated from noncolitic (TPH1/) mice and cultured
with medium or with serotonin (107M) with or without LPS (100 ng/ml) and
with or without NF-B inhibitor (PDTC; 10 mol/L). The levels of IL-12p40
present in the culture supernatant were investigated by ELISA. *P  0.05
compared with control. **P  0.05. Data are representative of two indepen-
dent experiments with quadruplicated cultures, mean  SEM.culture supernatant from naive TPH1/ mice was ob-
served compared with TPH1/ mice (Figure 3A).
However, addition of serotonin in culture media of DCs
from TPH1/ mice significantly up-regulated IL-12p40
production compared with DCs from TPH1/ cultured
without the addition of serotonin (Figure 3A). Addition
of NF-B inhibitor PDTC in the culture media signifi-
cantly decreased the production of serotonin-stimu-
lated IL-12p40 cytokines by DCs in response to LPS.
Serotonin alone significantly increased the levels of
IL-12p40, and this effect was inhibited by the addition
of NF-B inhibitor (Figure 3B).
We also investigated the effect of serotonin on bone
marrow–derived dendritic cells (BMDCs) from naive
mice. Bone marrow progenitors were cultured in the
presence of GM-CSF to generate myeloid DCs.24
Serotonin dose dependently increased significantly
the release of IL-12p40 and IL-1 in cell culture super-
natant compared with untreated BMDCs (Figure 4, A
and B).
Serotonin Regulates the Ability of DC Priming of
CD4 T Cells
We next assessed whether the lack of serotonin in the
Figure 4. Effect of serotonin on IL-12p40 and IL-1 production from BM-
DCs. Bone marrow progenitors were cultured in the presence of GM-CSF (20
ng/ml) for 7 days to generate myeloid DCs. BMDCs were treated with
serotonin dose dependently (107, 105, and 103M) for 48 hours. The levels
of IL-12p40 (A) and IL-1 (B) present in the culture supernatant were
investigated by ELISA. *P  0.05 compared with medium. Data are repre-
sentative of two independent experiments with quadruplicated cultures us-
ing seven mice, mean  SEM.gut in TPH1/ mice can affect the ability of DCs to
TPH1 . **P  0.05 compared with naive DCs. Each value represents mean
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mice and cocultured with DCs isolated from colitic
TPH1/ mice released significantly lower amounts of
IL-17 and IFN- compared with CD4 T cells cocul-
tured with DCs isolated from colitic TPH1/ mice
when stimulated with LPS. Interestingly, in control con-
ditions in the presence of medium only, we also ob-
served a significant decrease in the amount of IL-17
and IFN- released in the culture supernatant of non-
stimulated DCs (Figure 5). We observed this immuno-
suppressive function of DCs isolated from TPH1/
mice on days 3, 5, and 7 of culture.
Adoptive Transfer of Serotonin-Pulsed DCs
Modulates DSS-Induced Colitis
We then investigated whether the transfer of serotonin-
pulsed DCs from noncolitic TPH1/ mice could influ-
ence the development of an acute colitis in TPH1/
mice. As illustrated in Figure 6, the deterioration of
colitis in mice receiving serotonin-pulsed DCs, com-
pared with untreated DCs, was evident in the 1.9-fold
increase in the macroscopic damage score (Figure 6A)
and in the 2.9-fold increase in MPO activity (Figure 5B).
Figure 5. Role of serotonin in function of DCs and sequential CD4 T-cell
activation. DCs from DSS-treated TPH1/ and TPH1/ were cultured in
the presence or absence of LPS for 24 hours before being cocultured with
CD4 T lymphocytes isolated from naive TPH1/ mice. Supernatant were
collected at day 3 (A), day 5 (B), and day 7 (C). The levels of IL-17 and IFN-
present in the culture supernatant were investigated by ELISA. *P  0.05
compared with medium. **P  0.05 compared with TPH1/. Data are
representative of two independent experiments with quadruplicated cultures
using seven mice, mean  SEM.The increased severity of DSS colitis in mice receivingFigure 6. Influence of adoptive transfer of DCs in the development of
DSS-induced colitis in TPH1/ mice Macroscopic score (A), MPO activity
(B), and histological score (C–D) after 5 days of DSS-induced colitis. DCs
(2.106 cells per mouse, i.p.) pulsed with serotonin (107M) for 24 hours
increased all of the different markers. *P  0.05 compared with control
/ SEM from eight mice.
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(Figure 6, C and D). The histological damage score
increased from 1.5  0.6 in mice receiving nonpulsed
DCs to 3.3  1.3 in mice transferred with serotonin-
pulsed DCs. Similarly, cytokine concentrations in the
colon were also increased in mice receiving serotonin-
pulsed DCs. The fold increase in IL-1 was 3.3 times
higher in mice receiving serotonin-pulsed DCs com-
pared with untreated mice with DSS-induced colitis,
and respective values for IL-6 and IL-17 were 1.7- and
1.3-fold increases. Levels of IL-1, IL-6, and IL-17 in co-
lonic tissue were significantly increased when mice were
transferred with nonpulsed DCs (Figure 7, A–D). The IL-4
level was not significantly modified.
Confirmation of the adoptive transfer was assessed
by the level of IL-12p40 in colonic tissue and serum.
The fold increase in IL-12 was significantly higher in 1.7
in colonic tissues and 1.8 in serum in mice receiving sero-
tonin-pulsed DCs compared with untreated TPH1/ DCs
(Figure 7, E and F).
Discussion
Mucosal inflammation in conditions ranging from infec-
tive acute enteritis or colitis to IBD is accompanied by
alteration in EC cell numbers and serotonin content in
Figure 7. Influence of adoptive transfer of DCs in TPH1/ mice cytokine
profile after induction of colitis. IL-1 (A), IL-6 (B), IL-17 (C), IL-4 (D), and
IL-12p40 (E) level in colonic tissue after 5 days of DSS-induced colitis. DCs
(2.106 cells per mouse, i.p.) pulsed with serotonin (107M) for 24 hours
increased all of the different markers but not IL-14 when transferred to a
TPH1/ mouse. F: IL-12p40 in serum was increased. *P  0.05 compared
with control TPH1/. **P  0.05 compared with naive DCs. Each value
represents mean  SEM from eight mice.the gut. It is now well recognized that this alteredserotonin response plays an important role in inflam-
mation-induced gut physiological changes, such as
motility and fluid and mucin secretion. There is also
emerging evidence that the immune system regulates
EC cell biology and serotonin production26 and sero-
tonin plays an important role in the generation of intes-
tinal inflammation and immune regulatory effects.3,8,27
Nevertheless, the precise mechanism by which sero-
tonin regulates intestinal inflammation and immune cell
function remains to be determined. DCs are key cells of
an innate immune system and play a crucial role in the
generation of adaptive immune response. Because of
the strategic location in the intestinal mucosa, DCs
may interact with EC cells and perform a key role in the
activation of the immune response and the generation
of gut inflammation. In this study, for the first time to our
knowledge, we provide evidence of an essential role of
serotonin in DC activation and generation of inflamma-
tion in the model of experimental colitis.
IBD, including mainly Crohn’s disease and ulcer-
ative colitis, is the most common and serious chronic
inflammatory condition of the human bowel.28,29 In-
flammation in the gut is characterized by mucosal re-
cruitment of a variety of inflammatory cells, including T
lymphocytes, macrophages, DCs, neutrophils, and
plasma cells. The persistent release of inflammatory
cytokines promotes adhesion, migration, and activa-
tion of immune and inflammatory cells and causes
tissue damage. Given the importance of the complex
network of cytokine profiles and its current applications
as targeted biological agents, precise analysis on the
source and mechanism of inflammatory cytokine pro-
duction is critical in developing effective therapeutic
strategy in IBD. DCs are powerful professional antigen-
presenting cells and are the orchestrators of the im-
mune response. DCs are not only responsible for link-
ing innate and adaptive immune response, they also
direct the type and quality of subsequent adaptive
immune responses in the context of the situation. DCs
have been implicated in Crohn’s disease pathogenesis
because defective migration and function of DCs and
aberrant immunogenic response to pathogens have
been suggested to contribute to the generation of in-
testinal inflammation.30 The importance of DCs in the
pathogenesis of colitis has been highlighted by the
findings that an increased number of DCs was found in
the mesenteric lymph nodes in the T-cell transfer
model of colitis31 and amelioration of DSS-induced
colitis by depletion of DCs after the administration of
diphtheria toxin in CD11c-DT receptor transgenic
mice.32 In IBD, CD11c DCs are activated, their ex-
pression of microbial recognition receptors is up-reg-
ulated, and more DCs produce inflammatory cytokines,
implying an important role of DCs in the pathogenesis
of IBD.33 CD is a TH1/TH17 cell–driven intestinal inflam-
matory disease, and once initiated, the inflamed tissue
is characterized by the expression of innate (IL-12p40,
IL-6, TNF-) and adoptive derived (IFN- and IL-17)
proinflammatory cytokines.34 TH1/TH17 differentiation
is controlled primarily by the IL-12 family of cytokines
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is induced by the addition of DSS polymers to the
drinking water and results in a reproducible acute coli-
tis characterized by colonic mucosal inflammation with
ulcerations, body weight loss, and bloody diarrhea.
Both innate and adaptive (TH1, TH17) immunological
mechanisms are shown to be important in the patho-
genesis of colitis in this model.36,37 Recent studies
from our laboratory demonstrated a key role of sero-
tonin in the development of DSS-induced colitis in
TPH1/ mice, which have reduced levels of serotonin
in the gut.8 This was associated with the down-regula-
tion of the production of proinflammatory cytokines (IL-
1, IL-6, and TNF-). We also observed that restoration
of serotonin levels in TPH1/ mice by the serotonin
precursor 5-hydroxytryptophan increased the severity
of DSS-induced colitis and the production of proinflam-
matory mediators. In this study, we have confirmed our
previous findings of attenuated DSS-induced colitis in
TPH1/ mice compared with the TPH1/ mice. We
also observed that this reduced severity of colitis in
TPH1/ mice is accompanied with down-regulation of
IL-12p40, IL-17, and IFN- levels in colonic tissues.
Given that there are other mediators in the in vivo set-
ting that may also contribute to the immune activation
and inflammatory process after DSS exposure, it was
important to confirm that the reduced inflammation
seen in TPH1/ mice is not due to factors other than
serotonin deficiency. We investigated the colonic lev-
els of PGE2 and histamine as potential mediators in the
process and observed absence of a significant differ-
ence in the levels of colonic PGE2 and histamine be-
tween TPH1/ and TPH1/ mice in DSS-induced
colitis, implying that serotonin is the critical factor for
the attenuation of inflammation in TPH1/ mice after
exposure to DSS. Our data on the proinflammatory role
of serotonin corroborate recent studies that demon-
strated that colitis induced by 2,4,6-trinitrobenzene
sulfonic acid or associated with IL-10 deficiency is
increased in severity when coupled with the serotonin–
enhancing effects of the knockout of serotonin re-
uptake transporter.27,38
The attenuated inflammation in DSS-induced colitis
was accompanied by reduced levels of IL-12p40 pro-
duction from DCs isolated from TPH1/ mice com-
pared with the DCs from TPH1/ mice. We also ob-
served that DCs isolated from noncolitic TPH1/ mice
produced significantly less IL-12p40 in response to
LPS compared with the TPH1/ mice. However, in
vitro stimulation with serotonin restored IL-12p40 pro-
duction from DCs isolated from naive TPH1/ mice.
Serotonin also stimulated IL-12p40 and IL-1 produc-
tion from BMDCs, which further imply an important role
of serotonin in immunomodulation. Serotoninergic re-
ceptors have been identified on DCs,18 and a recent
study demonstrated that by binding to serotonin 3,
serotonin 4, and serotonin 7 receptors, serotonin up-
regulated production of proinflammatory cytokines and
chemokines from DCs.39 It has also been suggested
that by up-taking serotonin at sites of inflammation,
DCs may shuttle serotonin to naive T cells and therebymodulate T-cell proliferation and differentiation.40 NF-
B–mediated overproduction of key proinflammatory
mediators (IL-1, IL-6, TNF-, IL-12, and nitric oxide) is
attributed to the initiation and progression of colonic
inflammation in both human and animal models.41,42
Serotonin can influence regulation of gut inflammation
by modulating NF-B activation and production of pro-
inflammatory cytokines from innate immune cells. In
this study, we observed that serotonin-stimulated pro-
duction of proinflammatory cytokines by DCs was sig-
nificantly inhibited by the addition of NF-B inhibitor.
Taken together, these observations suggest that sero-
tonin plays an important role in activation of DC func-
tion via the NF-B signaling pathway and that the se-
rotonin-mediated modulation of DC function is critical
in the pathogenesis of colitis in this model.
Because TH1- and TH17-type immune responses
have been characterized in DSS-induced colitis36 and
DCs play a crucial role in priming the immune response
to TH1 and TH17 cells, we next examined whether re-
duced levels of serotonin in TPH1/ mice have any
influence on T-cell priming and production of TH1 and
TH17 cytokines. Our results demonstrated that DCs
isolated from DSS-treated TPH1/ mice had a signif-
icantly reduced ability to stimulate naive CD4 T cells
in vitro to produce IFN- and IL-17 compared with the
DCs isolated from DSS-treated TPH1/ mice. In ad-
dition, in studies on the adoptive transfer of serotonin-
pulsed DCs, we observed a significant increase in
macroscopic and histological scores in TPH1/ mice
that received serotonin-pulsed DCs along with DSS
administration compared with the TPH1/ mice that
received DCs without serotonin pulsing. This was as-
sociated with significant up-regulation of MPO activity
and inflammatory cytokines (IL-1, IL-6, IL-12p40, and
IL-17). These observations further provide evidence in
favor of a crucial role of serotonin in DC function in
relation to generation of gut inflammation.
Taken together, these studies show an important
role of serotonin in the pathogenesis of inflammation in
the gut by influencing proinflammatory cytokine pro-
duction from DCs via activation of the NF-B pathway
and sequential T-cell instigation. These observations
provide new insight on the mechanism of gut inflam-
mation. In addition to enhancing our understanding of
the pathogenesis of colitis, this study provides novel
information on serotonin in the context of immune cell
signaling. Serotonin deficiency is not only shown to be
important in modulating intestinal inflammation, recent
studies have shown that serotonin deficiency causes
slower growth of colon cancer allografts in vivo43 and
reduces development of osteoporosis by promoting
bone formation.44 Thus, the data obtained from the
present study are important not only in understanding
the mechanism of GI inflammation but also in gaining
insight into the pathogenesis of non-GI disorders
where there is alteration in serotonin signaling. In a
wider perspective, these data may have an implication
in understanding the role of this gut hormone in the
pathogenesis of both GI and non-GI inflammation,
670 Li et al
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strategies in inflammatory disorders.
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